CJC-1295 (Modified Growth Hormone-Releasing Factor 1-29) – 2MG per vial

Clinical Test Expectation – CJC-1295 – Human Subjects : Increased growth hormone secretion and IGF-1 Levels with no increase in prolactin. Increased body weight and length through increased protein synthesis. Increased muscle growth and bone density. Improved immune function, cognition and memory. Increased collagen production, fat loss and cellular repair and regeneration.
Strength – 2MG per vial

Introduction
CJC-1295 is a synthetic GHRH (growth hormone releasing hormone) analogue made up of 30 amino acids. It has been found to be highly effective with regards to the increase of growth hormone secretion and IGF-1 without negatively affecting the pulsatility of GH secretion.

CJC-1295 is often combined with Ipamorelin due to its enhanced specificity as a GHRH. This peptide generates similar increases in growth hormone secretion, but without the appetite stimulation and increase in cortisol, acetylcholine, prolactin, and aldosterone seen with other peptides in its class. This peptide has been found to be very well-tolerated and perfect when combined with Ipamorelin.

CJC 1295 offers many benefits to the body, including:

• Increased growth hormone secretion and IGF-1 Levels with no increase in prolactin
• Increased Body Weight and Length through increased protein synthesis
• Increased Muscle Growth
• Increased Bone Density
• Improved Immune Function
• Improved Cognition and Memory
• Increased Collagen Production
• Increased Fat Loss
• Increased Cellular Repair and Regeneration

CJC-1295 also promotes slow wave deep sleep, which is responsible for the highest level of muscle growth and memory retention and rejuvenation.

Dosing Details – Please visit this link for Dosing instructions : https://researchpeptides.co.za/dosage-instructions/